MMV prioritizes the needs of women and girls, a key population at risk of malaria.
Here are recent key milestones in this area:
- One pregnancy registry established in Kenya, with permission granted for expansion to Burkina Faso
- Studies have shown the zebrafish assay to be a reliable tool for the prediction of embryotoxicity in mammals, which could help pave the way for earlier inclusion of pregnant women in clinical trials
→Read more about the malaria and gender equity
→Read more about MMV's Malaria in Mothers and Babies strategy